StockData
Impact BioMedical Inc. logo

Impact BioMedical Inc. (IBO) stock

IBONYSEPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 6/30
$3.06+0.38 (+14.18%)

Close on Oct 19, 2026Market cap $329.93MP/E –Yield –

Impact BioMedical revenue

Revenue is the money a company takes in from selling its products and services, before any costs are deducted.

Impact BioMedical's revenue for the twelve months ending Jun 30, 2026 was $35.00K. For fiscal 2025 it was $32.00K, down 36.0% from the year before.

Annual revenue

PeriodPeriod endValueChange
FY2025Dec 31, 2025$32.00K-36.0%
FY2022Dec 31, 2022$50.00K–

Quarterly revenue

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$3.00K-57.1%
Q1 FY2026Mar 31, 2026$7.00K–
Q4 FY2025Dec 31, 2025$7.00K–
Q3 FY2025Sep 30, 2025$18.00K-64.0%
Q2 FY2025Jun 30, 2025$7.00K–
Q4 FY2022Dec 31, 2022$0–
Q3 FY2022Sep 30, 2022$0–
Q2 FY2022Jun 30, 2022$50.00K–

More Impact BioMedical figures

See a number that looks wrong?